Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07409142 · ClinicalTrials.gov registry record
BetterLife FSHD: A Patient-driven Health and Research Platform
A clinical trial of Facioscapulohumeral Muscular Dystrophy and FSHD, sponsored by FSHD Society.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT07409142 is a study of Facioscapulohumeral Muscular Dystrophy and FSHD that is actively recruiting participants, run by FSHD Society. The registered enrollment target is 5,000 participants, above the 679-participant average among 6 other Facioscapulohumeral Muscular Dystrophy trials with a reported enrollment target (636% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07409142, a study of Facioscapulohumeral Muscular Dystrophy and FSHD, is actively recruiting participants, sponsored by FSHD Society.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportunities that match their health experiences and needs. At the same time, BetterLife collects secure health and experience data from patients to support research. This data is shared with researchers to help better understand FSHD and work toward improved care, treatments, and outcomes for the community. Learn more and enroll at: www.BetterLifeFSHD.org
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Massachusetts
- FSHD Society - Randolph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-08-02 |
| Est. Completion | 2060-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07409142
The ClinicalTrials.gov registry entry for NCT07409142 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 679-participant average among 6 other Facioscapulohumeral Muscular Dystrophy trials with a reported enrollment target (636% higher). The listed sponsor is FSHD Society, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Facioscapulohumeral Muscular Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT07409142 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07409142 about?
NCT07409142 is a clinical study titled "BetterLife FSHD: A Patient-driven Health and Research Platform". BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportunities that match their health experiences and needs. At the same time, BetterLife collects secure health and experience data from patients to...
What is the current status of trial NCT07409142?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-08-02. Estimated completion is 2060-01.
What conditions does trial NCT07409142 study?
This clinical trial studies the following conditions: Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1, FSHD2.
What interventions are being tested in trial NCT07409142?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT07409142?
This trial is sponsored by FSHD Society, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07409142 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facioscapulohumeral Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
RECRUITING
-
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
RECRUITING
-
Biomarker Development for Muscular Dystrophies
RECRUITING
-
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
RECRUITING · Phase 1
-
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
RECRUITING · Phase 3
-
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.